CClinicalTrials.gg
CompletedNCT04932694Updated Feb 10, 2023

Optimizing Function Outcomes After Bariatric Surgery With Core Stabilization Training: A Randomized Controlled Study

An interventional study of Core stabilization training in Bariatric Surgery and Surgery, sponsored by Cairo University. Completed at 2 sites in 2 countries. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-02-10.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Bariatric surgery has been reported to be the most effective treatment option for losing and maintaining body weight and improving comorbidities and mortality associated with morbid obesity. Nevertheless, even though physical activity is recommended to optimize bariatric surgery results. Very little is known, about whether engaging in an exercise program after surgery can provide additional improvement in health outcomes. While to date there are relatively few researches studied the effect of exercise in patients who have undergone bariatric surgery.

Read the detailed description

This study will investigate the effect of core stabilization exercise on patients who underwent bariatric suergery.

02

Conditions studied

  • Bariatric Surgery
  • Surgery

Keywords

  • Bariatric surgery
  • Core training
  • Stabilization exercises
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Both male and female
  • age ranged from 18-25 years old,
  • at least 6 months after BS

Exclusion criteria

Exclusion Criteria:

  • Patients with nerve root compression
  • spine disorders
  • spinal fracture
  • previous spinal surgery
  • pregnancy
  • lower limb injury
  • Any contraindication to the exercise therapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Study group

    Core stabilization exercises will be conducted for 8 weeks, 3 sessions per day at home, and exercises will be supervised remotly.

    Other: Core stabilization training

  • No intervention
    Control group

    No exercise will be given to the participants in the control group

Interventions

  • OtherCore stabilization training

    Exercise training will be given to the participants in the study group in the form of core training exercises for 8 weeks.

    Also known as: Exercises

06

What researchers measure

Primary outcomes

  1. Core endurance tests

    These tests consisted of four positions and calculated the time spent during the test.

    Time frame: 2 months

  2. Flexor extensor isokinetic torque

    These tests consist of flexor and extensor isokinetic torque assessment.

    Time frame: 2 months

Secondary outcomes

  1. Balance assessment

    assess the body balance using balance biodex system

    Time frame: 2 months

  2. 6 min walking test

    Assess aerobic capacity and endurance by measuring the distance covered in 6 minutes

    Time frame: 2 months

  3. Function Assessment

    Assess function disability using Oswestry disability index questionnaire.

    Time frame: 2 months

  4. Trunk sense of position

    Assess position sense of the trunk

    Time frame: 2 months

07

Study locations

2 sites
  • Olfat Ibrahim Ali
    Giza, Dokki 12611, Egypt
  • Olfat Ibrahim Ali
    Jeddah, 12611, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No — Participants data will not be shared.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04932694
Lead sponsor
Cairo University
Collaborators
Batterjee Medical College, Taif University
Responsible party
Olfat Ibrahim Ali (Assistant Professor, Cairo University) — Principal investigator
First posted
Jun 21, 2021
Start date
Jun 21, 2021
Primary completion
Nov 24, 2021
Completion
Nov 24, 2021
Last update
Feb 10, 2023

Study contacts

Olfat I Ali, PhD
principal investigator · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion